Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: CNS Drugs. 2019 Oct;33(10):1001–1030. doi: 10.1007/s40263-019-00664-w

Table 3.

Effects of fatty acid amide hydrolase inhibitors on drug-taking and drug-seeking behavior in experimental animals

Drug and dosage Species Results References
URB597
IP 0.01–0.3 mg/kg Rat No effect on PR responding for heroin [177]
IP 0.3–3 mg/kg Rat ↓ Brain-stimulation reward [230]
IP 0.5 mg/kg Mouse ↓ Preference for alcohol [189]
IV 0.1 mg/kg Rat ↓ VTA DA neuron response to nicotine [187]
IP 0.1, 0.3 mg/kg Rat ↓ Acquisition of nicotine self-administration [182]
↓ Acquisition of nicotine CPP
↓ Drug-primed reinstatement of nicotine seeking
IP 0.1–1 mg/kg Rat No effect on voluntary alcohol drinking [191]
No effect on PR responding for alcohol
No effect on drug-, cue-, or stress-induced reinstatement of alcohol seeking
↓ Anxiety during alcohol withdrawal
IV 0.3 mg/kg Monkey No effect on reinstatement of alcohol seeking [174]
↓ Sensitivity to alcohol sedation
↑ Recovery from alcohol-induced motor incoordination
IP 1–3 mg/kg Rat No effect on cocaine self-administration [175]
↓ Drug-primed reinstatement of cocaine seeking
↓ Cue-induced reinstatement of cocaine seeking
IP 0.3, 1 mg/kg Rat ↓ Cue-induced reinstatement of nicotine seeking [183]
↓ Drug-induced reinstatement of nicotine seeking
↓ Drug-induced reinstatement of nicotine seeking
IP 0.03–0.3 mg/kg Rat ↑ Extinction of CPA in morphine-treated rats [179]
IV 0.1 mg/kg Rat ↓ NAc GABA neuron response to nicotine or cocaine [188]
No effect on VTA DA neuron response to cocaine or morphine
IP 0.3 mg/kg Rat No effect on morphine CPP [178]
No effect on CPA induced by the morphine withdrawal
IP 0.1–1 mg/kg Rat ↓ Naloxone-induced opioid withdrawal symptoms [181]
IP 0.1, 0.3 mg/kg Rat ↓ Anxiety during nicotine withdrawal [186]
No effect on somatic symptoms of nicotine withdrawal
IP 0.3, 1, 3 mg/kg Rat ↓ Cue-induced reinstatement of cocaine seeking [176]
↓ Stress-induced reinstatement of cocaine seeking
IV 0.1–1 mg/kg Monkey No effect on cocaine self-administration [185]
↓ Nicotine self-administration
↓ Cue-induced reinstatement of nicotine seeking
IP 0.3 mg/kg Rat ↓ Drug-primed reinstatement of nicotine seeking [183]
IP 0.5 mg/kg Mouse ↓ Alcohol consumption [192]
↓ Alcohol tolerance
IP 10 mg/kg Mouse ↓ Withdrawal symptoms from Δ9-THC [218]
PF-3845
IP 10 mg/kg Mouse ↓ Naloxone-precipitated withdrawal from morphine [180]
IP 1–10 mg/kg Mouse No effect on morphine withdrawal symptoms [218]
No effect on morphine withdrawal-induced CPA

CPA conditioned place aversion, CPP conditioned place preference, DA dopamine, GABA γ-aminobutyric acid, IP intraperitoneally, IV intravenously, NAc nucleus accumbens, PR progressive-ratio, VTA ventral tegmental area, Δ9-THC Δ9-tetrahydrocannabinol, ↓ and ↑ represent decrease and increase, respectively